NasdaqCM - Nasdaq Real Time Price USD

Psychemedics Corporation (PMD)

2.5500 -0.0700 (-2.67%)
At close: 4:00 PM EDT
2.7600 +0.21 (+8.24%)
After hours: 6:15 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Brian Hullinger President, CEO & Director 361.37k -- 1968
Ms. Daniella Mehalik Vice President of Finance 126.41k -- 1990
Ms. Shannon Shoemaker Chief Revenue Officer 187.82k -- --
Dr. Werner A. Baumgartner Ph.D. Founder -- -- --
Ms. Annette Baumgartner Founder -- -- --
Mr. Michael Weisenhoff Principal Financial & Accounting Manager -- -- 1990
Mr. Patrick J. Kinney Jr. Secretary -- -- --

Psychemedics Corporation

5220 Spring Valley Road
Suite 230
Dallas, TX 75254
United States
800 527 7424 https://www.psychemedics.com
Sector: 
Healthcare
Full Time Employees: 
116

Description

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas.

Corporate Governance

Psychemedics Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 07, 2024 - May 13, 2024
Psychemedics Corporation Earnings Call

Related Tickers

BIAFW bioAffinity Technologies, Inc.
0.4500
+12.50%
 
FONR FONAR Corporation
16.27
-3.50%
 
IDXG Interpace Biosciences, Inc.
1.5000
+5.45%
 
XGN Exagen Inc.
1.4121
+0.86%
 
SHC Sotera Health Company
11.40
+0.71%
 
BDSX Biodesix, Inc.
1.2350
-1.98%
 
AWH Aspira Women's Health Inc.
3.3266
+1.42%
 
TRIB Trinity Biotech plc
1.8300
0.00%
 
STIM Neuronetics, Inc.
3.4900
-0.85%
 
BNR Burning Rock Biotech Limited
0.8500
0.00%